Ifyoulook atthevast majorityof the dataand the meta-analyses thathavebeendone, it really shows nodifference in HCVrecurrence rates between bothcalcineurininhibitors.
However, a study carried out by the University of Michigan Cancer Centre has concluded that women with the genes haveno extra chance of either cancer recurrence, or these side-effects.